Eva 056
Eva 056
Eva 056
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses
Professional use
Industrial use
Product use : Two component coating for interior and exterior use.
ethylenediamine REACH #: <1 Flam. Liq. 3, H226 ATE [Oral] = 500 [1] [3]
01-2119480383-37 Acute Tox. 4, H302 mg/kg
EC: 203-468-6 Acute Tox. 3, H311 ATE [Dermal] =
CAS: 107-15-3 Acute Tox. 4, H332 300 mg/kg
Skin Corr. 1B, H314 ATE [Inhalation
Eye Dam. 1, H318 (vapours)] = 11 mg/
Resp. Sens. 1, H334 l
Skin Sens. 1, H317
Aquatic Chronic 3,
H412
See Section 16 for
the full text of the H
statements declared
above.
There are no additional ingredients present which, within the current knowledge of the supplier and in the
concentrations applicable, are classified as hazardous to health or the environment, are PBTs, vPvBs or Substances of
equivalent concern, or have been assigned a workplace exposure limit and hence require reporting in this section.
Type
[1] Substance classified with a health or environmental hazard
[2] Substance with a workplace exposure limit
[3] Substance of equivalent concern
Occupational exposure limits, if available, are listed in Section 8.
4.2 Most important symptoms and effects, both acute and delayed
There are no data available on the mixture itself. The mixture has been assessed following the conventional method
of the CLP Regulation (EC) No 1272/2008 and is classified for toxicological properties accordingly. See Sections 2
and 3 for details.
Exposure to component solvent vapor concentrations in excess of the stated occupational exposure limit may result in
adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
Ingestion may cause nausea, diarrhea and vomiting.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : In case of inhalation of decomposition products in a fire, symptoms may be delayed.
The exposed person may need to be kept under medical surveillance for 48 hours.
Specific treatments : No specific treatment.
6.2 Environmental : Avoid dispersal of spilled material and runoff and contact with soil, waterways,
precautions drains and sewers. Inform the relevant authorities if the product has caused
environmental pollution (sewers, waterways, soil or air).
Recommended monitoring : If this product contains ingredients with exposure limits, personal, workplace
procedures atmosphere or biological monitoring may be required to determine the effectiveness
of the ventilation or other control measures and/or the necessity to use respiratory
protective equipment. Reference should be made to monitoring standards, such as
the following: European Standard EN 689 (Workplace atmospheres - Guidance for
the assessment of exposure by inhalation to chemical agents for comparison with
limit values and measurement strategy) European Standard EN 14042 (Workplace
atmospheres - Guide for the application and use of procedures for the assessment
of exposure to chemical and biological agents) European Standard EN 482
(Workplace atmospheres - General requirements for the performance of procedures
for the measurement of chemical agents) Reference to national guidance
documents for methods for the determination of hazardous substances will also be
required.
DNELs/DMELs
Product/ingredient name Type Exposure Value Population Effects
Reaction mass of ethylbenzene and DNEL Long term Oral 1.6 mg/kg General Systemic
xylene bw/day population
DNEL Long term 14.8 mg/m³ General Systemic
Inhalation population
DNEL Long term 77 mg/m³ Workers Systemic
Inhalation
DNEL Long term Dermal 108 mg/kg General Systemic
bw/day population
DNEL Long term Dermal 180 mg/kg Workers Systemic
bw/day
DNEL Short term 289 mg/m³ Workers Local
Inhalation
10.3 Possibility of : Under normal conditions of storage and use, hazardous reactions will not occur.
hazardous reactions
10.4 Conditions to avoid : Avoid all possible sources of ignition (spark or flame). Do not pressurize, cut, weld,
braze, solder, drill, grind or expose containers to heat or sources of ignition.
10.6 Hazardous : Under normal conditions of storage and use, hazardous decomposition products
decomposition products should not be produced.
Exposure to component solvent vapor concentrations in excess of the stated occupational exposure limit may result in
adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
Ingestion may cause nausea, diarrhea and vomiting.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Delayed and immediate effects and also chronic effects from short and long term exposure
Short term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Long term exposure
Potential immediate : Not available.
effects
Potential delayed effects : Not available.
Potential chronic health effects
Not available.
Conclusion/Summary : Not available.
General : No known significant effects or critical hazards.
The mixture has been assessed following the summation method of the CLP Regulation (EC) No 1272/2008 and is
not classified as hazardous to the environment, but contains substance(s) hazardous to the environment. See section
3 for details.
Conclusion/Summary : Not available.
14.6 Special precautions for : Transport within user’s premises: always transport in closed containers that are
user upright and secure. Ensure that persons transporting the product know what to do in
the event of an accident or spillage.
National regulations
Biocidal products regulation
International regulations
Chemical Weapon Convention List Schedules I, II & III Chemicals
Not listed.
Montreal Protocol
Not listed.
Stockholm Convention on Persistent Organic Pollutants
Not listed.
Rotterdam Convention on Prior Informed Consent (PIC)
Not listed.
UNECE Aarhus Protocol on POPs and Heavy Metals
Not listed.
15.2 Chemical Safety : No Chemical Safety Assessment has been carried out.
Assessment
Brand names mentioned in this data sheet are trademarks of or are licensed to Akzo Nobel.